Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to 1.26%.

  • Coeptis Therapeutics Holdings' Return on Capital Employed changed N/A to 1.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.26%, marking a year-over-year change of. This contributed to the annual value of 4.52% for FY2024, which is 20900.0% up from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Return on Capital Employed is 1.26%.
  • Coeptis Therapeutics Holdings' 5-year Return on Capital Employed high stood at 1.0% for Q3 2022, and its period low was 7.47% during Q4 2023.
  • Over the past 4 years, Coeptis Therapeutics Holdings' median Return on Capital Employed value was 2.28% (recorded in 2024), while the average stood at 3.58%.
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Return on Capital Employed crashed by -56200bps in 2023 and then surged by 52000bps in 2024.
  • Coeptis Therapeutics Holdings' Return on Capital Employed (Quarter) stood at 1.85% in 2022, then plummeted by -303bps to 7.47% in 2023, then soared by 70bps to 2.28% in 2024, then skyrocketed by 45bps to 1.26% in 2025.
  • Its Return on Capital Employed was 1.26% in Q3 2025, compared to 1.54% in Q2 2025 and 2.02% in Q1 2025.